Bio-Techne Corporation (TECH)
NASDAQ: TECH · Real-Time Price · USD
59.58
+0.31 (0.52%)
Oct 15, 2025, 4:00 PM EDT - Market closed
Bio-Techne Employees
Bio-Techne had 3,100 employees as of June 30, 2025. The number of employees did not change compared to the previous year.
Employees
3,100
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$393,431
Profits / Employee
$23,665
Market Cap
9.28B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Jun 30, 2025 | 3,100 | 0 | - |
Jun 30, 2024 | 3,100 | 50 | 1.64% |
Jun 30, 2023 | 3,050 | 50 | 1.67% |
Jun 30, 2022 | 3,000 | 400 | 15.38% |
Jun 30, 2021 | 2,600 | 300 | 13.04% |
Jun 30, 2020 | 2,300 | 50 | 2.22% |
Jun 30, 2019 | 2,250 | 250 | 12.50% |
Jun 30, 2018 | 2,000 | 200 | 11.11% |
Jun 30, 2017 | 1,800 | 240 | 15.38% |
Jun 30, 2016 | 1,560 | 204 | 15.04% |
Jun 30, 2015 | 1,356 | 335 | 32.81% |
Jun 30, 2014 | 1,021 | 167 | 19.56% |
Jun 30, 2013 | 854 | 7 | 0.83% |
Jun 30, 2012 | 847 | 13 | 1.56% |
Jun 30, 2011 | 834 | 97 | 13.16% |
Jun 30, 2010 | 737 | -9 | -1.21% |
Jun 30, 2009 | 746 | 27 | 3.76% |
Jun 30, 2008 | 719 | 38 | 5.58% |
Jun 30, 2007 | 681 | 44 | 6.91% |
Jun 30, 2006 | 637 | 28 | 4.60% |
Jun 30, 2005 | 609 | 12 | 2.01% |
Jun 30, 2004 | 597 | 11 | 1.88% |
Jun 30, 2003 | 586 | 16 | 2.81% |
Jun 30, 2002 | 570 | 9 | 1.60% |
Jun 30, 2001 | 561 | 64 | 12.88% |
Jun 30, 2000 | 497 | 26 | 5.52% |
Jun 30, 1999 | 471 | 60 | 14.60% |
Jun 30, 1998 | 411 | 46 | 12.60% |
Jun 30, 1997 | 365 | -7 | -1.88% |
Jun 30, 1996 | 372 | 28 | 8.14% |
Jun 30, 1995 | 344 | 67 | 24.19% |
Jun 30, 1994 | 277 | 71 | 34.47% |
Jun 30, 1993 | 206 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
TECH News
- 1 day ago - Saguaro Biosciences Partners with Bio-Techne to Distribute Innovative Live-Cell Imaging Reagents - Business Wire
- 1 day ago - Bio-Techne to Host Conference Call on November 5, 2025, to Announce First Quarter Fiscal 2026 Financial Results - PRNewsWire
- 7 days ago - Bio-Techne and Oxford Nanopore Technologies Expand Agreement to Accelerate Development of Genetics Portfolio Through 2032 - PRNewsWire
- 20 days ago - Bio-Techne Advances Spatial Biology Solutions Bridging Translational Research to Clinical Applications - PRNewsWire
- 22 days ago - Bio-Techne Highlights Progress on Climate, Innovation, and Culture in 2025 Sustainability Report - PRNewsWire
- 5 weeks ago - Bio-Techne Corporation (TECH) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 5 weeks ago - Bio-Techne Corporation (TECH) Presents At Baird Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 5 weeks ago - ScaleReady Awards G-Rex® Grants to Support Cell and Gene Therapy Manufacturing in California - PRNewsWire